doi: 10.1056/NEJMc0808738.
Reports of esophageal cancer with oral bisphosphonate use
- PMID: 19118315
- DOI: 10.1056/NEJMc0808738
Item in Clipboard
Reports of esophageal cancer with oral bisphosphonate use
N Engl J Med.
.
No abstract available
Comment in
-
More on reports of esophageal cancer with oral bisphosphonate use.N Engl J Med. 2009 Apr 23;360(17):1789; author reply 1791-2. doi: 10.1056/NEJMc096026. N Engl J Med. 2009. PMID: 19387022 No abstract available.
-
More on reports of esophageal cancer with oral bisphosphonate use.N Engl J Med. 2009 Apr 23;360(17):1789-90; author reply 1791-2. N Engl J Med. 2009. PMID: 19391255 No abstract available.
-
More on reports of esophageal cancer with oral bisphosphonate use.N Engl J Med. 2009 Apr 23;360(17):1790; author reply 1791-2. N Engl J Med. 2009. PMID: 19391256 No abstract available.
-
More on reports of esophageal cancer with oral bisphosphonate use.N Engl J Med. 2009 Apr 23;360(17):1790-1; author reply 1791-2. N Engl J Med. 2009. PMID: 19391257 No abstract available.
-
More on reports of esophageal cancer with oral bisphosphonate use.N Engl J Med. 2009 Apr 23;360(17):1790; author reply 1791-2. N Engl J Med. 2009. PMID: 19391258 No abstract available.
-
More on reports of esophageal cancer with oral bisphosphonate use.N Engl J Med. 2009 Apr 23;360(17):1791; author reply 1791-2. N Engl J Med. 2009. PMID: 19391259 No abstract available.
Similar articles
-
More on reports of esophageal cancer with oral bisphosphonate use.N Engl J Med. 2009 Apr 23;360(17):1790-1; author reply 1791-2. N Engl J Med. 2009. PMID: 19391257 No abstract available.
-
More on reports of esophageal cancer with oral bisphosphonate use.N Engl J Med. 2009 Apr 23;360(17):1789-90; author reply 1791-2. N Engl J Med. 2009. PMID: 19391255 No abstract available.
-
More on reports of esophageal cancer with oral bisphosphonate use.N Engl J Med. 2009 Apr 23;360(17):1790; author reply 1791-2. N Engl J Med. 2009. PMID: 19391258 No abstract available.
-
An evaluation of the use of oral bisphosphonates and risk of esophageal cancer.Ann Pharmacother. 2012 Mar;46(3):419-23. doi: 10.1345/aph.1Q482. Epub 2012 Feb 14. Ann Pharmacother. 2012. PMID: 22333262 Review.
-
[Diphosphonate therapy and osteonecrosis of the jaw].Tidsskr Nor Laegeforen. 2007 Aug 9;127(15):1945-7. Tidsskr Nor Laegeforen. 2007. PMID: 17700737 Review. Norwegian. No abstract available.
Cited by
-
Epidemiological distribution of high-risk human papillomavirus genotypes and associated factors among patients with esophageal carcinoma at Bugando medical center in Mwanza, Tanzania.BMC Cancer. 2024 Aug 1;24(1):932. doi: 10.1186/s12885-024-12657-0. BMC Cancer. 2024. PMID: 39090618 Free PMC article.
-
Bone Targeting Nanoparticles for the Treatment of Osteoporosis.Int J Nanomedicine. 2024 Feb 12;19:1363-1383. doi: 10.2147/IJN.S444347. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38371454 Free PMC article. Review.
-
Trends in Management of Osteoporosis Following Primary Vertebral Compression Fracture.J Endocr Soc. 2023 Jun 20;7(7):bvad085. doi: 10.1210/jendso/bvad085. eCollection 2023 Jun 5. J Endocr Soc. 2023. PMID: 37388575 Free PMC article.
-
Receptor activator of nuclear factor-κB ligand-mediated osteoclastogenesis signaling pathway and related therapeutic natural compounds.Front Pharmacol. 2022 Nov 9;13:1043975. doi: 10.3389/fphar.2022.1043975. eCollection 2022. Front Pharmacol. 2022. PMID: 36438811 Free PMC article. Review.
-
Dentistry and Drug Adverse Events: Between Responsibilities and Regulations.Toxics. 2022 Nov 7;10(11):671. doi: 10.3390/toxics10110671. Toxics. 2022. PMID: 36355962 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
